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Pseudomonas aeruginosa is a re-emerging, multidrug-resistant, opportunistic pathogen
that threatens the lives of immunocompromised patients, patients with cystic fibrosis,
and those in critical care units. One of the most important virulence factors in
this pathogen is the siderophore pyoverdine. Pyoverdine serves several critical roles
during infection. Due to its extremely high affinity for ferric iron, pyoverdine gives
the pathogen a significant advantage over the host in their competition for iron. In
addition, pyoverdine can regulate the production of multiple bacterial virulence factors
and perturb host mitochondrial homeostasis. Inhibition of pyoverdine biosynthesis
decreases P. aeruginosa pathogenicity in multiple host models. To better understand the
regulation of pyoverdine production, we developed a high-throughput genetic screen
that uses the innate fluorescence of pyoverdine to identify genes necessary for its
biosynthesis. A substantial number of hits showing severe impairment of pyoverdine
production were in genes responsible for early attachment and biofilm formation. In
addition to genetic disruption of biofilm, both physical and chemical perturbations also
attenuated pyoverdine production. This regulatory relationship between pyoverdine and
biofilm is particularly significant in the context of P. aeruginosa multidrug resistance,
where the formation of biofilm is a key mechanism preventing access to antimicrobials
and the immune system. Furthermore, we demonstrate that the biofilm inhibitor
2-amino-5,6-dimethylbenzimidazole effectively attenuates pyoverdine production and
rescuesCaenorhabditis elegans fromP. aeruginosa-mediated pathogenesis. Our findings
suggest that targeting biofilm formation in P. aeruginosa infections may have multiple
therapeutic benefits and that employing an unbiased, systems biology-based approach
may be useful for understanding the regulation of specific virulence factors and
identifying novel anti-virulence therapeutics or new applications for existing therapies for
P. aeruginosa infections.
Keywords: Pseudomonas aeruginosa, biofilm, pyoverdine, Caenorhabditis elegans, c-di-GMP, high-throughput
screen, biofilm inhibitors, anti-virulence
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INTRODUCTION
Antibiotic resistance is a catastrophic, re-emerging threat to
health care. Multidrug-resistant nosocomial infections increase
the danger to hospitalized patients and drastically increase
healthcare costs (Brusselaers et al., 2011). Despite the fact that
multi-drug resistant P. aeruginosa is already responsible for more
than 13% of hospital-acquired P. aeruginosa infections, poor
understanding of P. aeruginosa pathogenesis has limited viable
treatments to conventional antimicrobials (Centers for Disease
Control and Resistance, 2013). This is problematic for several
reasons. First, P. aerguinosa forms antibiotic resistant biofilms
that are extremely difficult to disperse and that limit penetration
of drugs or the immune system. Second, P. aeruginosa expresses
a number of multidrug eﬄux pumps, which further reduce
intracellular antibiotic concentrations (Lomovskaya et al., 2001).
Third, the pathogen readily acquires additional resistance
mechanisms from other microbes. These phenomena make it
imperative that we develop new treatments, beyond conventional
antimicrobials.
The most promising alternative approach for limiting
P. aeruginosa infection is to identify mechanisms to limit its
virulence, rather than its growth. This target is complicated
however, as mechanisms underlying pathogenesis vary widely,
depending on infection conditions and environmental factors.
A short, and incomplete, list of virulence factors encoded by P.
aeruginosa includes cyanide- and phenazine-based toxins, type
three secretion effectors, phospholipases, and exotoxins (Meyers
and Berk, 1990; Gallagher and Manoil, 2001; Diaz and Hauser,
2010). P. aeruginosa also secretes the siderophore pyoverdine,
which is necessary for full pathogenesis in various mammalian
and non-mammalian hosts (Takase et al., 2000; Imperi et al.,
2013; Kirienko et al., 2013; Lopez-Medina et al., 2015; Minandri
et al., 2016).
The reason for this requirement remains unclear, but has
generally been attributed to two different activities of pyoverdine.
First, pyoverdine exhibits extremely high affinity to ferric iron
(1032 M−1), which is sufficient to remove iron from mammalian
iron-sequestering proteins such as lactoferrin and transferrin
(Meyer et al., 1996; Xiao and Kisaalita, 1997). Iron is required for
all life, and is extremely restricted within the host; pyoverdine is
likely to help meet this demand. Beyond its role in scavenging
iron, pyoverdine is also known to regulate the production of
multiple other pathogenic determinants, such as the translational
inhibitor exotoxin A and the protease PrpL (Lamont et al., 2002).
A recently established Caenorhabditis elegans-based
pathogenesis model suggests an additional function for
pyoverdine in virulence: it directly exerts cytotoxicity by
removing host iron, inducing mitochondrial damage, mitophagy,
and a lethal hypoxic crisis in the host (Kirienko et al., 2013, 2015).
Multiple transcriptome analyses indicate that pyoverdine may
also be involved in other aspects of P. aeruginosa pathogenesis,
including quorum sensing and responding to reactive oxygen
species (ROS) (Palma et al., 2004; Dietrich et al., 2006).
Furthermore, small molecule pyoverdine biosynthesis inhibitors,
such as 5-fluorocytosine and 5-fluorouridine are sufficient to
rescue mice and C. elegans (Imperi et al., 2013; Costabile et al.,
2016; Kirienko et al., 2016). This demonstrates the utility of
limiting pyoverdine production in P. aeruginosa infections.
In large part due to its significance in virulence, a substantial
body of work on the regulation of pyoverdine biosynthesis
exists. The most directly relevant factor is the alternative sigma
factor PvdS, which is regulated at both the transcriptional
and post-transcriptional levels (Cunliffe et al., 1995). At the
transcriptional level, pvdS expression is regulated by several
factors, including intracellular iron concentration via the ferric
uptake regulator (FUR) (Ochsner et al., 1995). Recently, the
LysR-type transcriptional regulators CysB, OxyR, and PA2206
have been show to regulate pvdS expression under conditions
of iron deficiency (former) or oxidative stress (latter two)
(Imperi et al., 2010; Wei et al., 2012; Reen et al., 2013; Llamas
et al., 2014). Post-transcriptionally, PvdS activity is controlled by
FpvR, which sequesters PvdS to the inner leaflet of the plasma
membrane (Edgar et al., 2014). PvdS’s transcriptional control is
also influenced by the regulator AlgQ, which helps to recruit
RpoD (Ambrosi et al., 2005). AlgQ is well-known for its role in
activating alginate biosynthesis, which plays a critical role during
chronic P. aeruginosa lung infections (Pedersen et al., 1990).
This was one of the earliest reports linking the regulation of
pyoverdine production to virulence factors that are not directly
related to iron homeostasis.
To gain better insight into pyoverdine regulation, we
performed a high-throughput genetic screen in P. aeruginosa to
identify genes necessary for pyoverdine production. A substantial
fraction of gene hits were involved in initial attachment and
biofilm formation, particularly those responsible for flagellin
synthesis, chemotaxis, and type IV pili synthesis. This suggests
that biofilm formation is required for pyoverdine production.We
also showed that disrupting biofilm formation either genetically
or chemically was sufficient to rescueC. elegans from pyoverdine-
mediated pathogenesis. We demonstrated that cyclic-diguanylate
monophosphate (c-di-GMP), a secondary messenger and master
regulator of virulence factors in the pathogen, regulates
pyoverdine production in a biofilm-dependent manner. On this
basis, we discovered that 2-amino-5,6-dimethylbenzimidazole, a
biofilm inhibitor, inhibits pyoverdine virulence.
MATERIALS AND METHODS
Strains and Growth Conditions
Strains used are listed in Table 1. For all pyoverdine production
and biofilm formation assays, bacteria were seeded in M9 media
(M9 salts (1% w/v) and casamino acids (1% w/v), supplemented
with 1 mM MgSO4 and 1 mM CaCl2) in static six-well plates
(Greiner, North Carolina) at 30◦C. SK media was composed of
0.35% (w/v) Bacto-Peptone and 0.3% (w/v) NaCl, supplemented
with 1 mMMgSO4 and 1 mM CaCl2 (Conery et al., 2014).
Transposon Mutant Library Screen
PA14 transposon mutants were inoculated into 96-well plates
with LB media containing 15 µg/mL gentamicin. Inoculated
plates were incubated overnight at 35◦C. 10 µL of LB culture
from each well were transferred into 96-well, clear, flat-bottom
plates (Greiner, North Carolina) containing 90 µL of M9 media
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TABLE 1 | Plasmids and strains used in this study.
Strains Relevant genotype Source or reference
PLASMIDS
Constitutive RFP
Expression
pUC19::dsRED AmpR Kirienko et al., 2013
pvdA reporter Mini-CTX2::PpvdA-gfp TcR Yang et al., 2009
P. aeruginosa PA14 STRAINS
PA14 WT Rahme et al., 1995
1pelA PA14∆pelA Kuchma et al., 2007
1flgK PA14∆flgK Shanks et al., 2006;
Kuchma et al., 2010
1pilY1 PA14∆pilY1 Kuchma et al., 2010
1motAB PA14∆motA∆motB Kuchma et al., 2015
1pvdA PA14∆pvdA Shanks et al., 2006;
Kuchma et al., 2010
pvdE PA14pvdE GentR Liberati et al., 2006
1sadC PA14∆sadC Merritt et al., 2007
1bifA PA14∆bifA Kuchma et al., 2007
1bifA∆pelA PA14∆bifA∆pelA Kuchma et al., 2007
P. aeruginosa PAO1 STRAINS
PAO1 WT Holloway et al., 1994
pelB PAO1pelB TcR Jacobs et al., 2003
fliF PAO1fliF TcR Jacobs et al., 2003
pilG PAO1pilG TcR Jacobs et al., 2003
motA PAO1motA TcR Jacobs et al., 2003
C. elegans STRAINS
Temperature sensitive
mutant
glp-4(bn2ts) Beanan and Strome, 1992
AmpR: ampicillin resistant.
TcR: tetracycline resistant.
GentR: gentamicin resistant.
per well. Bacterial plates were grown at room temperature for
24 h. Pyoverdine production (Ex 405 nm, Em 460 nm) and
bacterial growth (O.D.600) were measured every hour in these
plates using a Cytation5 (BioTek, Vermont) multimode plate
reader.
Pyoverdine Production Kinetics Assay
Bacterial strains were grown in LB media with appropriate
antibiotics overnight with shaking. Two milliliters M9 media
were dispensed into each well in six-well plates (Greiner, North
Carolina) and inoculated with 100 µL from overnight LB
cultures. The plate was incubated at 30◦C inside a plate reader for
24 h with pyoverdine fluorescence measurements and bacterial
growth absorbance measurements made every 30 min. Each
experiment consisted of at least three biological replicates.
Biofilm Formation Assay
This procedure was adapted from (Merritt et al., 2005). In brief,
bacterial strains were grown under conditions identical to those
described above. After incubation at 30◦C for 24 h, bacterial
cultures were aspirated and the biofilm matrix on the bottom
of the plate was stained with 2 mL of 0.1% (w/v) crystal violet
in 20% (v/v) ethanol/water for 30 min. The stain was removed
and excess stain was washed with two consecutive rinses of PBS
(Gibco, Maryland). Plates were dried and then photographs were
taken. For biofilm quantification, the remaining crystal violet was
solubilized in 30% acetic acid and absorbance was measured at
550 nm. Each experiment consisted of at least three biological
replicates. Statistical significance was determined using Student’s
t-test.
RNA Purification and qRT-PCR
After 8 h growth in six-well plates, planktonic cells were
collected from 1.5 mL of supernatant. RNA was extracted and
purified using Trizol reagent (Invitrogen, California) according
to manufacturer’s protocols with minor adjustments. To ensure
cell lysis, cells resuspended in Trizol reagent were heated at
95◦C for 15 min prior to phase separation. Purified RNA was
treated with DNase I (Thermo Scientific, Massachusetts). Reverse
transcription was performed using random decamers and
Retroscript kit (Ambion). qRT-PCR was conducted using SYBR
green PerfeCTa SYBRGreen Fastmix (Quantabio,Massachusetts)
in a CFX-96 real-time thermocycler (Bio-Rad, California). Fold-
changes were calculated using a 11Ct method, and compared
to expression from wild-type P. aeruginosa. Primer sequences are
available upon request.
Biofilm and Planktonic Cells Pyoverdine
Expression Measurement
Two milliliters of M9 media were dispensed into three wells of
a six-well plate (Greiner, North Carolina) and inoculated with
100 µL of PA14 dsRed/PpvdA-gfp LB overnight culture. After
incubation at 30◦C for 16 h, supernatant was carefully collected
from each well. Planktonic cells were collected from 1 mL of
media. Cells in biofilm were collected by scraping all three wells
into 1 mL of PBS buffer using a cell scraper. The two cells
samples were extensively washed and resuspended in 1 mL of
PBS. GFP and dsRed fluorescence from 100 µL of each sample
was measured in a black 96-well plate (Greiner, North Carolina).
Each experiment consisted of at least three biological replicates.
Statistical significance was determined using Student’s t-test.
Biofilm and Planktonic Cells Pyoverdine
Imaging
Two milliliters of M9 media were dispensed into each of three
wells in a six-well plate (Greiner, North Carolina) and inoculated
with 100 µL of P. aeruginosa grown overnight in LB. After 8
or 16 h incubation at 30◦C, supernatant was carefully collected
from all wells. Planktonic cells were collected from 2 mL of
media. Planktonic cells and biofilm-associated cells attached to
the bottom of the plate were washed twice with PBS. Planktonic
cells were resuspended in 0.5 mL PBS buffer and dispensed into
a six-well plate. Biofilms and concentrated planktonic cells were
imaged using a custom filter (445/45 excitation, 510/42 emission,
482 nm dichroic) using a Cytation5 multimode reader (Biotek,
Vermont). All images were taken under identical conditions, and
each experiment consisted of at least three biological replicates.
C. elegans Pathogenesis Assay
The procedure was adapted from (Kirienko et al., 2014). In brief,
glp-4(bn2ts) worms were grown at 25◦C on E. coliOP50 until they
reached young adulthood. Worms were washed off plates, rinsed
with S Basal, and resuspended in M9 media (500 worms/mL).
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1,000 worms were dispensed into each well of a six-well plate and
inoculated with 100 µL of overnight P. aeruginosa PA14 culture
grown in LB. Plates were covered with air-permeable membranes
and incubated at 25◦C for 30 h. After exposure to P. aeruginosa,
worms were collected from the wells and extensively washed
in S Basal buffer. Worms were pelleted by gravity between
washes to effectively remove most P. aeruginosa bacteria from
the media. After washes, 30–40 worms were dispensed into each
well of black half-area 96-well clear bottom plates (Greiner, North
Carolina). Worms were stained with Sytox Orange nucleic acid
stain (Thermo Fisher) for 12 h at room temperature. Excess
stain was removed by washing twice in S Basal, and plates were
imaged under bright field and RFP channels using a Cytation5
multimode plate reader (BioTek, Vermont). Relative host death
was quantified by normalizing RFP/bright field intensity in
worms. Killing of C. elegans by biofilm mutants was normalized
to that of wild-type P. aeruginosa. Each experiment consisted
of at least three biological replicates. Each biological replicate
contained 12 wells (∼400 worms). Statistical significance was
determined using Student’s t-test.
C. elegans’ Ferric Iron Quantification
glp-4(bn2ts) worms were grown at 25◦C on E. coli OP50 until
they reached young adulthood. Worms were washed off plates,
rinsed with S Basal, and resuspended in M9 media (3,000
worms/mL). 6,000 worms were dispensed into each well of
a six-well plate and inoculated with 100 µL of P. aeruginosa
PA14 grown overnight in LB. Three wells were used for each
condition for each biological replicate. Plates were covered
with air-permeable membranes and incubated at 25◦C for
36 h. Worms were collected and extensively washed in S
Basal buffer. To facilitate lysis, worms were frozen at –80◦C,
thawed, and sonicated. To quantify iron (III) concentration, 50
µL of pyoverdine-rich bacterial filtrate of known fluorescence
was added to 200 µL of lysate. After incubation, pyoverdine
fluorescence was measured with a Cytation5 (Biotek, Vermont),
and was compared to the same filtrate diluted with media.
Since pyoverdine binds to ferric iron in a 1:1 stoichiometric
ratio, the reduction of pyoverdine fluorescence reflects the ferric
iron content in the worm lysate. Iron concentrations in worms
exposed to biofilm mutants and to wild-type P. aeruginosa PA14
were compared. Each experiment consisted of at least three
biological replicates. Statistical significance was determined using
Student’s t-test.
Quantification of Biofilm and Pyoverdine in
Different Surface Growth Conditions
Twenty-five microliters of P. aeruginiosa PA14 grown overnight
in LB was inoculated into 475 µL of M9 media in 17 mm
diameter glass or plastic culture tubes. Tubes were grown
in 30◦C under static growth conditions for 16 h. Bacterial
supernatant was collected from the tubes, and pyoverdine
fluorescence was determined. Biofilms in tubes were stained
and crystal violet staining was measured as described above.
Each experiment consisted of at least three biological replicates.
Statistical significance was determined using Student’s t-test.
RESULTS
Transposon Mutant Library Screen Reveals
a Link between Biofilm Formation and
Pyoverdine Production
Using a non-redundant P. aeruginosa PA14 transposon mutant
library (Liberati et al., 2006), we conducted a high-throughput,
kinetic screen of 5,810 mutants to measure pyoverdine
production. The high-throughput screen was performed under
static growth conditions in 96-well plates, which resulted
in robust biofilm formation in most wells, supporting the
potential for a relationship between the generation of biofilm
and production of pyoverdine. Fluorescence spectrophotometry
(Ex 405 nm, Em 460 nm) was used to monitor pyoverdine
biosynthesis in 96-well plates over a 24 h span. Of the
mutants screened, 485 showed severe impairments in pyoverdine
fluorescence (as defined as production below 30% of wild-type
levels). Eliminating targets with growth defects (i.e., mutants
where reduced pyoverdine biosynthesis might be caused by poor
growth) left 338 hits. These were narrowed further to include
only 296 hits that had predicted gene function (Figures 1A,B).
55 of these (18.6%) were associated with various stages of
biofilm formation (Figure 1C), including flagellin biosynthesis,
chemotaxis, type IV pili assembly, Cup fimbriae biogenesis, and
exopolysaccharide synthesis (Table S1).
To verify our findings, we selected genes representative for
each stage of biofilm formation (initial surface attachment: flgK, a
flagellum biosynthesis gene, andmotAB, required for chemotaxis;
adhesion factor production: pilY1, a type IV pili mutant; and
bioflm maturation: pelA, an exopolysacharide mutant) (Vogeleer
et al., 2014). As expected, these strains exhibited impairments in
both biofilm formation (Figure 2A) and pyoverdine production
(Figure 2B). We also observed a strong linear correlation
between the amount of biofilm and pyoverdine produced by these
mutants (Figure 2C), indicating a role for biofilm formation in
pyoverdine production.
Quantitative real-time PCR (qRT-PCR) using RNA harvested
from WT P. aeruginosa PA14, ∆pilY1, and ∆flgK planktonic
cells after 8 h growth corroborated this finding. We used qRT-
PCR to analyze expression of the alternative sigma factor pvdS
and pvdS-dependent pyoverdine biosynthesis genes [including
pvdA and pvdF (which are responsible for generating the
non-standard amino acid N-formyl-N-hydroxyornithine), pvdE
(predicted to transport nascent pyoverdine into the periplasm),
pvdP and pvdQ (involved in periplasmic maturation)] (Visca
et al., 2007; Drake and Gulick, 2011). All genes were significantly
downregulated in ∆flgK mutant (Figure 2D). As may be
hypothesized by the weaker pyoverdine biosynthesis phenotype
(Figure 2B), the∆pilY1mutant showed significantly less impact,
although several genes were still disrupted, including pvdF,
pvdP, and pvdQ. The PvdRT-OpmQ system is thought to
be responsible for recycling pyoverdine back out of the
periplasmic space (Imperi et al., 2009). Unsurprisingly (pvdT
is also transcriptionally regulated by pvdS), pvdT expression
was diminished in the ∆flgK mutant, although regulation of
opmQ, which is in the same operon as pvdR and pvdT)
was unaffected. Our qRT-PCR data also suggest a possible
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FIGURE 1 | PA14 transposon mutant library screen for genes essential for pyoverdine production. (A) Schematic diagram of library screening process with criteria for
identifying screen hits. (B) Kinetic data from a sample plate showing two mutants with severely impaired pyoverdine production (< 30% of normal, below the red
arrow). (C) Families of gene functions identified and their relative enrichment among hits identified in the screen.
role for ferripyoverdine uptake in biofilm-mediated regulation
of pyoverdine production. fpvA, the ferripyoverdine receptor
(Shen et al., 2002), and tonB1, which provides the energy for
ferripyoverdine translocation into the cell (Shirley and Lamont,
2009), were significantly downregulated in the ∆flgK mutant
(Figure 2D).
To determine whether the regulatory relationship between
pyoverdine and biofilm is bidirectional (i.e., whether pyoverdine
production was necessary for biofilm formation), we
assayed biofilm development in two mutants (PA14∆pvdA
and PA14pvdE). Pyoverdine production was abolished in
PA14∆pvdA (Figure 2B), while PA14pvdE produced a small
amount of pyoverdine (Figure 2B). Both mutants showed nearly
normal biofilm formation (Figure 2A). This is consistent with
previous results from Banin and colleagues, who showed that
active iron acquisition was necessary for biofilm formation, but
that pyoverdine itself is not (Banin et al., 2005).
P. aeruginosa strains exhibit tremendous variation in the
regulation of virulence genes (Lee et al., 2006). Therefore, we
tested whether biofilm formation was necessary for pyoverdine
production in PAO1, the reference strain for P. aeruginosa.
PAO1 mutants with transposons inserted into analogous
genes involved in biofilm formation (fliF and motA to disrupt
attachment, pilG to disrupt adhesion, and pelB to disrupt biofilm
maturation) generally exhibited compromised pyoverdine
production (Figures S1A,B). However, unlike PA14∆pelA
mutant, the PAO1pelB strain was capable of forming dense
biofilms comparable to wild-type bacteria (Figure S1A), resulting
in wild-type levels of pyoverdine production (Figure S1B).
This is likely due to the fact that PAO1 produces two different
types of exopolysaccharides, Pel and Psl, and the disruption
in Pel alone is insufficient to effectively decrease biofilm
formation and pyoverdine biosynthesis. This is consistent with
our observations that PAO1 appears to create more biofilm
than PA14 (Figure S2A). Interestingly, PAO1 also secretes
more pyoverdine and at a faster rate than PA14 (Figure S2B).
However, in genes that most disrupt biofilm formation (flgK
for PA14 and motAB for PAO1), pyoverdine production was
attenuated to similar levels in the two strains (Figure 2B,
Figure S1B).
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FIGURE 2 | Biofilm formation is necessary for pyoverdine production. (A) Biofilm matrix of PA14 or 6 PA14 mutants in six-well plates stained with 0.1% crystal violet
solution. (B) Pyoverdine fluorescence normalized to bacterial growth, measured kinetically over 24 h in biofilm mutants. (C) Scatterplot of pyoverdine and biofilm
produced in PA14 biofilm mutants grown in 6-well plate cultures. Biofilm was quantified by resuspending crystal violet stain in 30% acetic acid solution and measuring
absorbance at 550 nm. (D) qRT-PCR of genes involved in pyoverdine biosynthesis, secretion, and signaling in WT P. aeruginosa PA14, ∆pilY1 mutant, and ∆flgK
mutant. Gene expressions in biofilm mutants are normalized to those in wild-type. (E) Pyoverdine expression in planktonic and biofilm cells after 16 h growth
measured by GFP fluorescence from PpvdA-gfp construct normalized to constitutively expressed dsRed fluorescence. (F) Pyoverdine production in PA14 biofilm
matrix and planktonic cells imaged using pyoverdine-specific fluorescence filter. Data presented in (A–C), and (F) are representative results from three biological
replicates. Error bars in (D,E) represent SEM between three biological replicates. NS corresponds to p > 0.05, # corresponds to p < 0.05, and * corresponds to p <
0.01 (based on Student’s t-test). Pyoverdine production curves without bacterial growth normalization are available in Figure S6.
Based on these observations, we hypothesized that sessile
and planktonic cells would exhibit differences in pyoverdine
biosynthetic machinery. We used a GFP-based reporter to
assay expression of the pvdA gene, which was normalized
to constitutively-expressed dsRed. To our surprise, pvdA
transcription was indistinguishable between planktonic and
biofilm-associated cell populations (Figure 2E). However, we
observed significant differences in pyoverdine production
between sessile and planktonic cells in earlier stages of
bacterial growth when pyoverdine biosynthesis is initiated. Using
fluorescence microscopy, we visualized intracellular pyoverdine
levels in sessile cells aggregated in the biofilm matrix and
planktonic cells collected from the growth media after 8
h (when pyoverdine production is initiated), and 16 h of
growth (Figure 2F). At 8 h, pyoverdine fluorescence is detected
only in cells in the biofilm matrix, but at 16 h, pyoverdine
fluorescence is present in both biofilm matrix and concentrated
planktonic cells (Figure 2F). In a ∆pvdA mutant, neither
biofilm matrix cells nor planktonic cells exhibit fluorescence,
verifying that the fluorescence detected is from pyoverdine
(Figure S3A). These results suggest one possible model for
biofilm-dependent regulation of pyoverdine. First, pyoverdine
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production is initiated in the microcolonies that will nucleate
biofilm formation. Secreted pyoverdine binds to ferric iron,
returning to the pathogen via the ferripyoverdine receptor
protein FpvA (Shen et al., 2002). This increases the activity of
PvdS, upregulating pyoverdine biosynthesis genes in both sessile
and planktonic cells (Lamont et al., 2002; Llamas et al., 2014).
Attenuated pyoverdine fluorescence in the extracellular matrices
of biofilm mutants (Figure S3B) and the downregulation of
ferripyoverdine uptake genes in ∆pilY1 and ∆flgK planktonic
cells (Figure 2D) are consistent with this model.
Disrupting Biofilm Formation Alleviates
Pyoverdine-Mediated Virulence in
C. elegans
Pyoverdine is mainly involved in iron transport, and its
exceptionally high affinity for ferric iron grants the pathogen a
significant advantage over the host in the competition for iron
acquisition. We recently reported that exposure to pyoverdine
significantly disrupts host iron homeostasis, inducing a lethal
hypoxic response in C. elegans (Kirienko et al., 2013). Based on
these findings, we predicted that the attenuation of pyoverdine
production in P. aeruginosa biofilm mutants would limit their
virulence and their ability to remove iron from the host. We
used a fluorometric assay to determine relative ferric iron
concentration in C. elegans (see Materials and Methods for
details). As expected, C. elegans exposed to pelA, flgK, or pilY1
mutants exhibited significantly greater ferric iron retention than
pyoverdine-competent controls, similar to worms exposed to
PA14pvdE (Figure 3A).
To determine whether this was sufficient to alleviate
pyoverdine-mediated pathology, we exposed worms to wild-
type or biofilm mutants of P. aeruginosa for 30 h, washed
them extensively to remove the pathogen, and then stained
them with Sytox Orange, a cell-impermeant dye that stains only
dead worms. C. elegans exposed to biofilm mutants displayed
significant reductions in mortality compared to wild-type
P. aeruginosa (Figures 3B,C). Interestingly, biofilm mutations
FIGURE 3 | Impairment of biofilm formation mitigates pathogen virulence. (A) Relative ferric iron content in C. elegans lysates from worms exposed to PA14 biofilm
mutants. Detailed procedure is described in Materials and Methods. (B) Sytox Orange stain in worms exposed to PA14 biofilm mutants visualized by RFP channel
image merged with brightfield. (C) Host death among PA14 mutants was quantitatively compared by RFP fluorescence normalized to brightfield intensity. Relative host
death in biofilm mutants was normalized to death observed in worms exposed to wild-type PA14. (D) C. elegans slow kill assay survival curve for PA14 biofilm
mutants. Data presented in (B–D) are representative results from three biological replicates. Error bars in (A) represent SEM between three biological replicates. Error
bars in (C) represent SEM between 12 technical replicates. Asterisks indicate significant difference between conditions (p-value < 0.01, based on Student’s t-test).
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compromised virulence to a greater extent even than the pvdE
mutant (Figures 3B,C). This suggests that biofilm formationmay
contribute to virulence through multiple means.
To identify the effects of biofilm formation in a pathogenesis
model that is not dependent upon pyoverdine, we tested whether
biofilm mutants showed attenuation in an agar-based, intestinal
colonization assay known as Slow Killing (Kirienko et al., 2013).
With the exception of PA14 ∆pilY1, the biofilm mutants showed
wild-type levels of virulence (Figure 3D). These data were also
corroborated by screening results from Feinbaum and colleagues
(Feinbaum et al., 2012). A majority of biofilm mutants (again,
with the exception of mutants that compromised formation of
the type IV pili) had no effect in P. aeruginosa’s ability to kill
C. elegans.
Intracellular c-di-GMP Levels Modulate
Pyoverdine Production by Regulating
Biofilm
Cyclic diguanylate monophosphate (c-di-GMP) is a crucial
secondary messenger in P. aeruginosa that transcriptionally
regulates a wide variety of virulence factors, including type III
and type VI secretion (Moscoso et al., 2011). Previous research
has also linked intracellular c-di-GMP concentration to biofilm
formation. For example, diguanylate cyclases (i.e., SadC) are
involved in c-di-GMP synthesis and support increased formation
of biofilms (Kuchma et al., 2007; Merritt et al., 2007), while
phosphodiesterases (i.e., BifA) hydrolyze c-di-GMP and limit
biofilm formation (Kuchma et al., 2007; Merritt et al., 2007).
Under our screening conditions, PA14∆sadC (low c-di-GMP)
and PA14∆bifA (high c-di-GMP) mutants exhibited less and
more biofilm respectively (Figures 4A,B), which is consistent
with previously published data (Kuchma et al., 2007; Merritt
et al., 2007). As predicted, pyoverdine production was attenuated
in∆sadC and enhanced in∆bifAmutants (Figure 4C).
To test the regulatory relationship between c-di-GMP
concentration and biofilm formation in pyoverdine production,
we repeated the kinetics experiment with a PA14∆bifA∆pelA
double mutant that exhibits high intracellular c-di-GMP
concentrations (Kuchma et al., 2007), but poor biofilm
formation (Figures 4A,B). Since pyoverdine production was not
completely abolished in the PA14∆pelA mutant background,
the ramifications of bifA deletion on pyoverdine production
(whether augmented or decreased) can be observed. Pyoverdine
FIGURE 4 | Intracellular c-di-GMP concentrations modulate pyoverdine production in a biofilm-dependent manner. (A) Biofilm matrix of c-di-GMP biosynthesis
mutants stained with 0.1% crystal violet solution. (B) Crystal violet concentration measured by absorbance at 550 nm after biofilm matrix stain was solubilized in 30%
acetic acid. (C) Pyoverdine fluorescence normalized to bacterial growth was measured kinetically over 24 h in diguanylate cyclase and phosphodiesterase mutants
and the phosphodiesterase mutant with biofilm defect. Data presented in (A,C) are representative results from three biological replicates. Error bars in (B) represent
SEM between three biological replicates. Asterisks indicate significant difference between conditions (p-value < 0.01, based on Student’s t-test). Pyoverdine
production curves without bacterial growth normalization are available in Figure S6.
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production in the PA14∆bifA∆pelA double mutant was similar,
if not lower, to ∆pelA single mutant (Figure 4C), indicating
that regulation of pyoverdine via intracellular c-di-GMP
concentrations is hypostatic to biofilm formation. This confirms
that c-di-GMP’s effect on pyoverdine production is mediated
indirectly, via biofilm formation.
Chemical and Physical Modifiers of Biofilm
Formation Affect Pyoverdine Production
We hypothesized that chemical inhibition of biofilm formation,
like genetic disruption, would reduce pyoverdine production.
Several compounds are known to compromise P. aeruginosa
biofilm formation, including the aromatic heterocycle 2-
amino-5,6-dimethylbenzimidazole (2-ABI) (Frei et al., 2012).
Addition of 25 µM 2-ABI to P. aeruginosa culture reduced
biofilm formation by 40% compared to the solvent control
(Figure 5A), with a concomitant decrease (60%) in pyoverdine
production (Figure 5B). The decrease in these exoproducts
was not a consequence of bacterial growth inhibition; bacterial
titer was unaffected by the presence of the compound
(Figure 5C). As expected, disruption of biofilm formation
and pyoverdine production by the addition of 2-ABI were
sufficient to rescue C. elegans (Figures 5D,E), offering an
exciting possibility of utilizing this molecule as an anti-
virulent.
Another way to significantly alter biofilm formation is by
changing the surface characteristics of the vessel for P. aeruginosa
static cultures. In this case many of the off target effects that may
be induced by chemical inhibitors or genetic manipulations will
be eliminated. On a plastic surface, P. aeruginosa PA14 formed
approximately one-half of the biofilm as a glass surface (Figure
S4A). This led to ∼25% decrease in pyoverdine production
(Figure S4B).
Pyoverdine Production is also Regulated
by Iron Starvation and Nutrient Limitation
Arguably, the most important cellular function for pyoverdine
is iron acquisition. Since biofilm formation is necessary for
pyoverdine production, we hypothesized that biofilm mutants
would be compromised under conditions where pyoverdine
FIGURE 5 | Biofilm inhibitor significantly impairs pyoverdine production and attenuate P. aeruginosa virulence. (A) Quantification of crystal violet-stained biofilm matrix
solubilized in acetic acid for PA14 grown in M9 media with 25 µM 2-ABI or DMSO solvent control. (B) Pyoverdine fluorescence of bacterial supernatant after 24 h of
static growth for PA14 grown in conditions as above. (C) Bacterial growth measured kinetically over 24 h by absorbance at 600 nm for PA14 grown in conditions as
above. (D) Sytox Orange stain in worms exposed to PA14 in the presence of DMSO solvent or 25 µM 2-ABI visualized by RFP channel image merged with brightfield
image. (E) Host death under the two conditions was quantitatively compared by RFP fluorescence normalized to brightfield intensity. Host death in the presence of
2-ABI was normalized to that of DMSO control. All data presented are representative results from biological replicates. Error bars in (A,B,E) represent SEM between
12 technical replicates. Asterisks indicate significant difference between conditions (p-value < 0.01, based on Student’s t-test).
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is required for growth. To test this hypothesis, we assessed
their growth alongside PA14pvdE mutant in the presence of
1,10-phenanthroline, a ferrous iron chelator (Figure 6A). When
grown inmedia supplemented to a final concentration of 250µM
1,10-phenanthroline, growth was compromised in all strains, but
it was most severely curtailed in pvdE mutant. To our surprise,
neither growth nor pyoverdine production in biofilm mutants
in low iron conditions were significantly different from wild-
type bacteria (Figures 6A,B). This was not due to improvement
of biofilm formation; mutants still showed significantly reduced
biofilm under these conditions (Figures 6C,D). This observation
is consistent with findings by Hunter et al., who reported
that inhibiting ferrous iron acquisition in P. aeruginosa
reduces biofilm formation (Hunter et al., 2013).The recovery
of pyoverdine production in biofilm mutants treated with
1,10-phenanthroline demonstrates that biofilm formation and
pyoverdine biosynthesis can be unlinked. As predicted, 1,10-
phenanthroline also abolished the protection provided by biofilm
gene mutation in the Liquid Killing assay (Figures 6E,F). In
contrast, virulence in the pvdEmutant remained attenuated, even
in the presence of 1,10-phenanthroline. This demonstrated that
adding 1,10-phenanthroline does not abolish the importance of
pyoverdine in virulence.
We observed similar results for biofilm mutants grown
in the presence of the ferric iron chelator ethylenediamine-
N,N′-bis(2-hydroxyphenylacetic acid (EDDHA). Addition of
1 mg/mL EDDHA significantly reduced bacterial growth
and biofilm formation (Figures S5A,C). As a result, neither
growth nor pyoverdine production was attenuated in biofilm
mutants, but it was severely curtailed in the pvdE mutant
(Figures S5A,B). Observations from biofilm mutants treated
with 1,10-phenanthroline or EDDHA suggest that under normal
conditions, biofilm production is necessary for robust pyoverdine
biosynthesis, but when iron concentrations become strongly
limited, pyoverdine production becomes independent of biofilm
genes.
In addition to iron starvation, nutrient availability also
contributes to pyoverdine regulation. Previously, we reported
that biofilm mutants showed no attenuation of virulence in
C. elegans Liquid Killing (Kirienko et al., 2013). The media used
for those studies is comprised of low concentrations of sodium
chloride and peptone, diluted into buffered inorganic salts to
match the osmolarity of the host. This contrasts with the M9
media used in this study, which is better defined and more
nutritionally rich. Kinetic measurements of biofilm mutants
grown in SK media showed no significant decrease in pyoverdine
fluorescence (Figure 7A). In contrast to the M9 media used in
this study, SK media does not support dense bacterial growth nor
formation of dense biofilms (Figures 7B,C). Much like low-iron
conditions, this alleviates pyoverdine biosynthesis from biofilm
regulation.
Likewise, pyoverdine production in c-di-GMP biosynthesis
mutants (PA14∆sadC, PA14∆bifA) in the presence of 1,10-
phenanthroline (Figure 6G) or SK media (Figure 7D) also did
not significantly differ from that of wild-type bacteria. This
further supports our model where c-di-GMP affects pyoverdine
production indirectly via biofilm formation.
DISCUSSION
The increasing prevalence of multidrug resistant pathogens
demands a new therapeutic approach to treating nosocomial
infections. One possibility is to supplement antibiotics with
novel drugs that compromise pathogen virulence. However, in
order to develop these treatments, we need to first identify the
relevant determinants and clearly understand their regulatory
relationships. Toward this end, we screened a P. aeruginosa
transposon mutant library to identify genes necessary for
the production of pyoverdine. The innate fluorescence of
pyoverdine enabled us to take a high-throughput, kinetic
approach, monitoring pyoverdine production over 24 h. This
revealed a relationship between pyoverdine, c-di-GMP, and
biofilm in P. aeruginosa. Due to their physiological significance,
these three virulence factors have been extensively studied. For
example, multiple studies have demonstrated the importance of
pyoverdine in various mammalian and non-mammalian models,
most notably in GI tract colonization and lung infection models
in mice (Imperi et al., 2013; Kirienko et al., 2013; Lopez-Medina
et al., 2015; Minandri et al., 2016). The secondary messenger
c-di-GMP functions as a master switch between motility and
biofilm formation. Biofilms form a critical in vivo reservoir of
infection that is particularly resistant to the immune system and
antimicrobials (Costerton et al., 1999). Many previous studies
have demonstrated that siderophores, including pyoverdine, play
an important role in biofilm formation through their iron-
scavenging activity (Banin et al., 2005; Ojha and Hatfull, 2007;
Chhibber et al., 2013). Recent studies have suggested that
biofilms may also regulate pyoverdine (Visaggio et al., 2015).
For example, Chen et al., suggested that exopolysaccharides
may regulate pyoverdine production through the Gac/Rsm
pathway and the diguanylate cyclase SadC, via an unknown
mechanism (Chen et al., 2015). It is difficult to know how relevant
their conditions were, however, since they overexpressed the
diguanylate cyclase YedQ, leading to levels of c-di-GMP that
may not reflect biologically relevant conditions. Visaggio, et al.,
also saw a link between the Pel and Psl exopolysaccharides in
pyoverdine production. However, their data suggest that the
relevant function of these sugars is to drive cell aggregation in the
PAO1 strain. This aggregation appears to be the driving force for
pyoverdine production in their conditions (Visaggio et al., 2015).
Although our high-throughput genetic screen provided
valuable insight into the possibility of biofilm formation
regulating pyoverdine, further work demonstrated the
complexity of this regulation that was not interpretable from the
screen alone. For instance, qRT-PCR of genes associated with
pyoverdine biosynthesis and fluorescence microscopy of biofilm
matrices suggested that ferripyoverdine uptake may be involved
in biofilm-dependent regulation of pyoverdine production.
These findings suggest that biofilm formation, a process which is
not directly related to iron metabolism in the bacterium, utilizes
iron-sensitive mechanisms to regulate pyoverdine production.
Furthermore, we were able to break the connection between
biofilm synthesis and pyoverdine production in PA14, by either
limiting iron with 1,10-phenanthroline or EDDHA, or by using
low concentrations of the macromolecules that provide carbon
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FIGURE 6 | Biofilm formation doesn’t affect pyoverdine production under iron-starved conditions. (A) Bacterial growth for PA14 biofilm mutants grown in M9 media
with 250 µM 1,10-phenanthroline measured by absorbance at 600 nm after 24 h incubation at 30◦C. (B) Pyoverdine fluorescence normalized to bacterial growth
(Continued)
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FIGURE 6 | Continued
kinetically measured over 24 h in biofilm mutants grown in the presence of 250 µM phenanthroline. (C) Crystal violet-stained biofilm matrices of biofilm mutants grown
in the presence of phenanthroline. (D) Quantification of crystal violet stain by solubilizing stain in 30% acetic acid and measuring absorbance at 550 nm. (E) SYTOX
Orange stain in worms exposed to PA14 biofilm mutants grown in the presence of phenanthroline visualized by RFP channel image merged with brightfield. (F) Host
death among PA14 mutants was quantitatively compared by RFP fluorescence normalized to brightfield intensity. Relative host death in biofilm mutants was
normalized to death observed in worms exposed to wild-type PA14. (G) Pyoverdine fluorescence normalized to bacterial growth kinetically measured over 24 h in
c-di-GMP biosynthesis mutants grown in the presence of 250 µM phenanthroline. Data are representative results from three biological replicates. Error bars in (A,D,F)
represent SEM between 12 technical replicates. Asterisks indicate significant difference between conditions (p-value < 0.01, based on Student’s t-test). NS
corresponds to p > 0.05. Pyoverdine production curves without bacterial growth normalization are available in Figure S6.
FIGURE 7 | Biofilm formation doesn’t affect pyoverdine production in SK media. (A) Pyoverdine fluorescence normalized to bacterial growth measured kinetically over
24 h in biofilm mutants grown in SK media. (B) Difference in bacterial growth for bacteria grown in M9 or SK media measured by absorbance at 600 nm. (C)
Difference in biofilm formation for bacteria grown in M9 or SK media measured by crystal violet biofilm matrix stain solubilized in acetic acid. (D) Pyoverdine
fluorescence normalized to bacterial growth measured kinetically over 24 h in c-di-GMP biosynthesis mutants grown in SK media. All error bars represent SEM
between four technical replicates. Asterisks indicate significant difference between conditions (p-value < 0.01, based on Student’s t-test). Pyoverdine production
curves without bacterial growth normalization are available in Figure S6.
and nitrogen. For instance, in nutrient-poor SK media, bacterial
density is artificially restrained, which is likely to diminish
cell aggregation and decrease production of quorum sensing
molecules. M9 media, which is richer in nutrients, permits
more robust growth. This difference may explain the variations
in pyoverdine production and regulation that we observed.
Our data indicate that the regulation of virulence factors like
pyoverdine are highly complex, multifactorial, and are likely to
take into account the conditions both within and outside of the
bacterium.
Finally, we were also able to demonstrate that genetic
or biochemical disruption of biofilm formation was sufficient
to attenuate pyoverdine-mediated pathogenesis. This was an
unexpected finding, as we had previously ruled out a role
for biofilm formation in pyoverdine-mediated pathogenesis in
the C. elegans liquid killing model (Kirienko et al., 2013).
As proof of principle, we demonstrated that 2-amino-5,6-
dimethylbenzimidazole, a small molecule inhibitor of biofilm
formation, was effective in limiting P. aeruginosa virulence. This
result also suggests a wider theme: disrupting any of the genes
that we have shown to regulate pyoverdine production (including
targets involved in motility, chemotaxis, signal transduction,
or amino acid biosynthesis) may attenuate virulence without
substantially compromising bacterial growth (which would place
selective pressure on the pathogen to develop resistance). The
interrelationships of virulence pathways demonstrate that it
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may be possible to compromise more than one pathogenic
determinant with a single drug, which is particularly appealing.
The innate fluorescence of pyoverdine dramatically simplifies
the process of identifying regulators of pyoverdine biosynthesis
using high-throughput screening approaches; fluorescence is
a nearly ideal readout for this type of screen. It should be
admitted that regulators of virulence factors lacking ready
detection techniques would be much harder to identify in
this fashion. Arguably, the most effective method in these
cases is to leverage model organisms to screen libraries (small
molecule, transposon, RNAi, etc.) for pathogenesis; C. elegans
and zebrafish are commonly used for this purpose (Begun
et al., 2005; Miller and Neely, 2005; Garvis et al., 2009; Kizy
and Neely, 2009; Feinbaum et al., 2012; Kirienko et al., 2016),
because they are small, have rapid generation times, and exhibit
strong evolutionary similarity to humans. This approach has
been particularly successful in identifying drugs that might be
repurposed to treat infectious diseases (Carvalho et al., 2011;
Imperi et al., 2013; Kirienko et al., 2016; Kim et al., 2017).
However, as noted above, this approach strictly requires that the
virulence mechanisms, and their regulation, can be recapitulated
in these models. If this demand can be met, this approach seems
an invaluable resource for making discoveries ranging from the
basic (e.g., the interconnectivity of regulatory networks that are
involved in a variety of metabolic processes) to the clinical (i.e.,
the identification of therapeutics that can transform health care
and postpone the rapidly approaching antimicrobial crisis).
AUTHOR CONTRIBUTIONS
Conceptualization: DK and NK; Data Collection: DK; Data
Analysis and Interpretation: DK and NK; Drafting: DK and NK;
Critical Revision: DK and NK; Funding Acquisition: NK.
FUNDING
This study was supported by the National Institute of Health
grant K22 AI110552 and by Welch Foundation grant C-1930
awarded to NK.
ACKNOWLEDGMENTS
We thank Dr. George A. O’Toole for providing the PA14 in-
frame deletion mutants.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fmicb.
2017.01707/full#supplementary-material
REFERENCES
Ambrosi, C., Tiburzi, F., Imperi, F., Putignani, L., and Visca, P. (2005).
Involvement of AlgQ in transcriptional regulation of pyoverdine
genes in Pseudomonas aeruginosa PAO1. J. Bacteriol. 187, 5097–5107.
doi: 10.1128/JB.187.15.5097-5107.2005
Banin, E., Vasil, M. L., and Greenberg, E. P. (2005). Iron and Pseudomonas
aeruginosa biofilm formation. Proc. Natl. Acad. Sci. U.S.A. 102, 11076–11081.
doi: 10.1073/pnas.0504266102
Beanan, M. J., and Strome, S. (1992). Characterization of a germ-line proliferation
mutation in C. elegans. Development 116, 755–766.
Begun, J., Sifri, C. D., Goldman, S., Calderwood, S. B., and Ausubel, F. M.
(2005). Staphylococcus aureus virulence factors identified by using a high-
throughput Caenorhabditis elegans-killing model. Infect. Immun. 73, 872–877.
doi: 10.1128/IAI.73.2.872-877.2005
Brusselaers, N., Vogelaers, D., and Blot, S. (2011). The rising problem of
antimicrobial resistance in the intensive care unit. Ann. Intensive Care 1:47.
doi: 10.1186/2110-5820-1-47
Carvalho, R., de Sonneville, J., Stockhammer, O. W., Savage, N. D., Veneman, W.
J., Ottenhoff, T. H., et al. (2011). A high-throughput screen for tuberculosis
progression. PLoS ONE 6:e16779. doi: 10.1371/journal.pone.0016779
Centers for Disease Control and Resistance (2013). Antibiotic Resistance
Threats in the United States, 2013. Available online at: https://www.cdc.
gov/drugresistance/pdf/ar-threats-2013-508.pdf. Government Document ID
CS239559-B.
Chen, Y., Yuan, M., Mohanty, A., Yam, J. K., Liu, Y., Chua, S. L., et al.
(2015). Multiple diguanylate cyclase-coordinated regulation of pyoverdine
synthesis in Pseudomonas aeruginosa. Environ. Microbiol. Rep. 7, 498–507.
doi: 10.1111/1758-2229.12278
Chhibber, S., Nag, D., and Bansal, S. (2013). Inhibiting biofilm formation
by Klebsiella pneumoniae B5055 using an iron antagonizing molecule
and a bacteriophage. BMC Microbiol. 13:174. doi: 10.1186/1471-2180-1
3-174
Conery, A. L., Larkins-Ford, J., Ausubel, F. M., and Kirienko, N. V.
(2014). High-throughput screening for novel anti-infectives using a
C. elegans pathogenesis model. Curr. Protoc. Chem. Biol. 6, 25–37.
doi: 10.1002/9780470559277.ch130160
Costabile, G., d’Angelo, I., d’Emmanuele di Villa Bianca, R., Mitidieri, E., Pompili,
B., Del Porto, P., et al. (2016). Development of inhalable hyaluronan/mannitol
composite dry powders for flucytosine repositioning in local therapy of lung
infections. J. Control. Release 238, 80–91. doi: 10.1016/j.jconrel.2016.07.029
Costerton, J. W., Stewart, P. S., and Greenberg, E. P. (1999). Bacterial
biofilms: a common cause of persistent infections. Science 284, 1318–1322.
doi: 10.1126/science.284.5418.1318
Cunliffe, H. E., Merriman, T. R., and Lamont, I. L. (1995). Cloning and
characterization of pvdS, a gene required for pyoverdine synthesis in
Pseudomonas aeruginosa: PvdS is probably an alternative sigma factor. J.
Bacteriol. 177, 2744–2750. doi: 10.1128/jb.177.10.2744-2750.1995
Diaz, M. H., and Hauser, A. R. (2010). Pseudomonas aeruginosa cytotoxin ExoU
is injected into phagocytic cells during acute pneumonia. Infect. Immun. 78,
1447–1456. doi: 10.1128/IAI.01134-09
Dietrich, L. E., Price-Whelan, A., Petersen, A., Whiteley, M., and Newman, D. K.
(2006). The phenazine pyocyanin is a terminal signalling factor in the quorum
sensing network of Pseudomonas aeruginosa. Mol. Microbiol. 61, 1308–1321.
doi: 10.1111/j.1365-2958.2006.05306.x
Drake, E. J., and Gulick, A. M. (2011). Structural characterization and high-
throughput screening of inhibitors of PvdQ, an NTN hydrolase involved
in pyoverdine synthesis. ACS Chem. Biol. 6, 1277–1286. doi: 10.1021/cb20
02973
Edgar, R. J., Xu, X., Shirley, M., Konings, A. F., Martin, L. W., Ackerley, D. F., et al.
(2014). Interactions between an anti-sigma protein and two sigma factors that
regulate the pyoverdine signaling pathway in Pseudomonas aeruginosa. BMC
Microbiol. 14:287. doi: 10.1186/s12866-014-0287-2
Feinbaum, R. L., Urbach, J. M., Liberati, N. T., Djonovic, S., Adonizio, A.,
Carvunis, A. R., et al. (2012). Genome-wide identification of Pseudomonas
aeruginosa virulence-related genes using a Caenorhabditis elegans infection
model. PLoS Pathog. 8:e1002813. doi: 10.1371/journal.ppat.1002813
Frei, R., Breitbach, A. S., and Blackwell, H. E. (2012). 2-Aminobenzimidazole
derivatives strongly inhibit and disperse Pseudomonas aeruginosa biofilms.
Angew. Chem. Int. Ed Engl. 51, 5226–5229. doi: 10.1002/anie.201109258
Frontiers in Microbiology | www.frontiersin.org 13 September 2017 | Volume 8 | Article 1707
Kang and Kirienko Biofilm Influences Pyoverdine Production
Gallagher, L. A., and Manoil, C. (2001). Pseudomonas aeruginosa PAO1 kills
Caenorhabditis elegans by cyanide poisoning. J. Bacteriol. 183, 6207–6214.
doi: 10.1128/JB.183.21.6207-6214.2001
Garvis, S., Munder, A., Ball, G., de Bentzmann, S., Wiehlmann, L., Ewbank, J.
J., et al. (2009). Caenorhabditis elegans semi-automated liquid screen reveals
a specialized role for the chemotaxis gene cheB2 in Pseudomonas aeruginosa
virulence. PLoS Pathog. 5:e1000540. doi: 10.1371/journal.ppat.1000540
Holloway, B. W., Römling, U., and Tümmler, B. (1994). Genomic mapping
of Pseudomonas aeruginosa PAO. Microbiology 140(Pt 11), 2907–2929.
doi: 10.1099/13500872-140-11-2907
Hunter, R. C., Asfour, F., Dingemans, J., Osuna, B. L., Samad, T., Malfroot, A., et al.
(2013). Ferrous iron is a significant component of bioavailable iron in cystic
fibrosis airways.MBio 4:e00557-13. doi: 10.1128/mBio.00557-13
Imperi, F., Massai, F., Facchini, M., Frangipani, E., Visaggio, D., Leoni, L.,
et al. (2013). Repurposing the antimycotic drug flucytosine for suppression
of Pseudomonas aeruginosa pathogenicity. Proc. Natl. Acad. Sci. U.S.A. 110,
7458–7463. doi: 10.1073/pnas.1222706110
Imperi, F., Tiburzi, F., Fimia, G. M., and Visca, P. (2010). Transcriptional control
of the pvdS iron starvation sigma factor gene by the master regulator of
sulfur metabolism CysB in Pseudomonas aeruginosa. Environ. Microbiol. 12,
1630–1642. doi: 10.1111/j.1462-2920.2010.02210.x
Imperi, F., Tiburzi, F., and Visca, P. (2009). Molecular basis of pyoverdine
siderophore recycling in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U.S.A.
106, 20440–20445. doi: 10.1073/pnas.0908760106
Jacobs, M. A., Alwood, A., Thaipisuttikul, I., Spencer, D., Haugen, E., Ernst, S., et al.
(2003). Comprehensive transposon mutant library of Pseudomonas aeruginosa.
Proc. Natl. Acad. Sci. U.S.A. 100, 14339–14344. doi: 10.1073/pnas.20362
82100
Kim, W., Hendricks, G. L., Lee, K., and Mylonakis, E. (2017). An update
on the use of C. elegans for preclinical drug discovery: screening and
identifying anti-infective drugs. Expert Opin. Drug Discov. 12, 625–633.
doi: 10.1080/17460441.2017.1319358
Kirienko, D. R., Revtovich, A. V., and Kirienko, N. V. (2016). A high-content,
phenotypic screen identifies fluorouridine as an inhibitor of pyoverdine
biosynthesis and Pseudomonas aeruginosa virulence. mSphere 1:e00217-16.
doi: 10.1128/mSphere.00217-16
Kirienko, N. V., Ausubel, F. M., and Ruvkun, G. (2015). Mitophagy confers
resistance to siderophore-mediated killing by Pseudomonas aeruginosa. Proc.
Natl. Acad. Sci. U.S.A. 112, 1821–1826. doi: 10.1073/pnas.1424954112
Kirienko, N. V., Cezairliyan, B. O., Ausubel, F. M., and Powell, J. R.
(2014). Pseudomonas aeruginosa PA14 pathogenesis in Caenorhabditis elegans.
Methods Mol. Biol. 1149, 653–669. doi: 10.1007/978-1-4939-0473-0_50
Kirienko, N. V., Kirienko, D. R., Larkins-Ford, J., Wahlby, C., Ruvkun, G., and
Ausubel, F.M. (2013). Pseudomonas aeruginosa disruptsCaenorhabditis elegans
iron homeostasis, causing a hypoxic response and death. Cell Host Microbe 13,
406–416. doi: 10.1016/j.chom.2013.03.003
Kizy, A. E., andNeely,M. N. (2009). First Streptococcus pyogenes signature-tagged
mutagenesis screen identifies novel virulence determinants. Infect. Immun. 77,
1854–1865. doi: 10.1128/IAI.01306-08
Kuchma, S. L., Ballok, A. E., Merritt, J. H., Hammond, J. H., Lu, W., Rabinowitz, J.
D., et al. (2010). Cyclic-di-GMP-mediated repression of swarming motility by
Pseudomonas aeruginosa: the pilY1 gene and its impact on surface-associated
behaviors. J. Bacteriol. 192, 2950–2964. doi: 10.1128/JB.01642-09
Kuchma, S. L., Brothers, K. M., Merritt, J. H., Liberati, N. T., Ausubel, F. M.,
and O’Toole, G. A. (2007). BifA, a cyclic-Di-GMP phosphodiesterase, inversely
regulates biofilm formation and swarming motility by Pseudomonas aeruginosa
PA14. J. Bacteriol. 189, 8165–8178. doi: 10.1128/JB.00586-07
Kuchma, S. L., Delalez, N. J., Filkins, L. M., Snavely, E. A., Armitage, J. P.,
and O’Toole, G. A. (2015). Cyclic di-GMP-mediated repression of swarming
motility by Pseudomonas aeruginosa PA14 requires the MotAB stator. J.
Bacteriol. 197, 420–430. doi: 10.1128/JB.02130-14
Lamont, I. L., Beare, P. A., Ochsner, U., Vasil, A. I., and Vasil, M. L.
(2002). Siderophore-mediated signaling regulates virulence factor production
in Pseudomonasaeruginosa. Proc. Natl. Acad. Sci. U.S.A. 99, 7072–7077.
doi: 10.1073/pnas.092016999
Lee, D. G., Urbach, J. M., Wu, G., Liberati, N. T., Feinbaum, R. L., Miyata, S.,
et al. (2006). Genomic analysis reveals that Pseudomonas aeruginosa virulence
is combinatorial. Genome Biol. 7:R90. doi: 10.1186/gb-2006-7-10-r90
Liberati, N. T., Urbach, J. M., Miyata, S., Lee, D. G., Drenkard, E., Wu, G.,
et al. (2006). An ordered, nonredundant library of Pseudomonas aeruginosa
strain PA14 transposon insertion mutants. Proc. Natl. Acad. Sci. U.S.A. 103,
2833–2838. doi: 10.1073/pnas.0511100103
Llamas, M. A., Imperi, F., Visca, P., and Lamont, I. L. (2014). Cell-surface signaling
in Pseudomonas: stress responses, iron transport, and pathogenicity. FEMS
Microbiol. Rev. 38, 569–597. doi: 10.1111/1574-6976.12078
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee,
M., et al. (2001). Identification and characterization of inhibitors of
multidrug resistance eﬄux pumps in Pseudomonas aeruginosa: novel agents
for combination therapy. Antimicrob. Agents Chemother. 45, 105–116.
doi: 10.1128/AAC.45.1.105-116.2001
Lopez-Medina, E., Fan, D., Coughlin, L. A., Ho, E. X., Lamont, I. L., Reimmann,
C., et al. (2015). Candida albicans inhibits Pseudomonas aeruginosa virulence
through suppression of pyochelin and pyoverdine biosynthesis. PLoS Pathog.
11:e1005129. doi: 10.1371/journal.ppat.1005129
Merritt, J. H., Brothers, K. M., Kuchma, S. L., and O’Toole, G. A. (2007).
SadC reciprocally influences biofilm formation and swarming motility via
modulation of exopolysaccharide production and flagellar function. J. Bacteriol.
189, 8154–8164. doi: 10.1128/JB.00585-07
Merritt, J. H., Kadouri, D. E., and O’Toole, G. A. (2005). Growing and
analyzing static biofilms. Curr. Protoc. Microbiol. Chapter 1, Unit 1B.1.
doi: 10.1002/9780471729259.mc01b01s00
Meyer, J. M., Neely, A., Stintzi, A., Georges, C., and Holder, I. A. (1996).
Pyoverdin is essential for virulence of Pseudomonas aeruginosa. Infect. Immun.
64, 518–523.
Meyers, D. J., and Berk, R. S. (1990). Characterization of phospholipase C from
Pseudomonas aeruginosa as a potent inflammatory agent. Infect. Immun. 58,
659–666.
Miller, J. D., and Neely, M. N. (2005). Large-scale screen highlights the importance
of capsule for virulence in the zoonotic pathogen Streptococcus iniae. Infect.
Immun. 73, 921–934. doi: 10.1128/IAI.73.2.921-934.2005
Minandri, F., Imperi, F., Frangipani, E., Bonchi, C., Visaggio, D., Facchini, M., et al.
(2016). Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and
Airway Infection. Infect. Immun. 84, 2324–2335. doi: 10.1128/IAI.00098-16
Moscoso, J. A., Mikkelsen, H., Heeb, S., Williams, P., and Filloux, A. (2011).
The Pseudomonas aeruginosa sensor RetS switches type III and type
VI secretion via c-di-GMP signalling. Environ. Microbiol. 13, 3128–3138.
doi: 10.1111/j.1462-2920.2011.02595.x
Ochsner, U. A., Vasil, A. I., and Vasil, M. L. (1995). Role of the ferric
uptake regulator of Pseudomonas aeruginosa in the regulation of siderophores
and exotoxin A expression: purification and activity on iron-regulated
promoters. J. Bacteriol. 177, 7194–7201. doi: 10.1128/jb.177.24.7194-720
1.1995
Ojha, A., and Hatfull, G. F. (2007). The role of iron in Mycobacterium smegmatis
biofilm formation: the exochelin siderophore is essential in limiting iron
conditions for biofilm formation but not for planktonic growth.Mol. Microbiol.
66, 468–483. doi: 10.1111/j.1365-2958.2007.05935.x
Palma, M., DeLuca, D., Worgall, S., and Quadri, L. E. (2004). Transcriptome
analysis of the response of Pseudomonas aeruginosa to hydrogen peroxide. J.
Bacteriol. 186, 248–252. doi: 10.1128/JB.186.1.248-252.2004
Pedersen, S. S., Kharazmi, A., Espersen, F., and Høiby, N. (1990). Pseudomonas
aeruginosa alginate in cystic fibrosis sputum and the inflammatory response.
Infect. Immun. 58, 3363–3368.
Rahme, L. G., Stevens, E. J., Wolfort, S. F., Shao, J., Tompkins, R. G., and Ausubel,
F. M. (1995). Common virulence factors for bacterial pathogenicity in plants
and animals. Science 268, 1899–1902. doi: 10.1126/science.7604262
Reen, F. J., Haynes, J. M., Mooij, M. J., and O’Gara, F. (2013). A non-
classical LysR-type transcriptional regulator PA2206 is required for an effective
oxidative stress response in Pseudomonas aeruginosa. PLoS ONE 8:e54479.
doi: 10.1371/journal.pone.0054479
Shanks, R. M., Caiazza, N. C., Hinsa, S. M., Toutain, C. M., and O’Toole, G. A.
(2006). Saccharomyces cerevisiae-based molecular tool kit for manipulation of
genes from gram-negative bacteria. Appl. Environ. Microbiol. 72, 5027–5036.
doi: 10.1128/AEM.00682-06
Shen, J., Meldrum, A., and Poole, K. (2002). FpvA receptor involvement
in pyoverdine biosynthesis in Pseudomonas aeruginosa. J. Bacteriol. 184,
3268–3275. doi: 10.1128/JB.184.12.3268-3275.2002
Frontiers in Microbiology | www.frontiersin.org 14 September 2017 | Volume 8 | Article 1707
Kang and Kirienko Biofilm Influences Pyoverdine Production
Shirley, M., and Lamont, I. L. (2009). Role of TonB1 in pyoverdine-
mediated signaling in Pseudomonas aeruginosa. J. Bacteriol. 191, 5634–5640.
doi: 10.1128/JB.00742-09
Takase, H., Nitanai, H., Hoshino, K., and Otani, T. (2000). Impact of siderophore
production on Pseudomonas aeruginosa infections in immunosuppressed
mice. Infect. Immun. 68, 1834–1839. doi: 10.1128/IAI.68.4.1834-18
39.2000
Visaggio, D., Pasqua, M., Bonchi, C., Kaever, V., Visca, P., and Imperi, F.
(2015). Cell aggregation promotes pyoverdine-dependent iron uptake
and virulence in Pseudomonas aeruginosa. Front. Microbiol. 6:902.
doi: 10.3389/fmicb.2015.00902
Visca, P., Imperi, F., and Lamont, I. L. (2007). Pyoverdine siderophores:
from biogenesis to biosignificance. Trends Microbiol. 15, 22–30.
doi: 10.1016/j.tim.2006.11.004
Vogeleer, P., Tremblay, Y. D., Mafu, A. A., Jacques, M., and Harel, J.
(2014). Life on the outside: role of biofilms in environmental persistence
of Shiga-toxin producing Escherichia coli. Front. Microbiol. 5:317.
doi: 10.3389/fmicb.2014.00317
Wei, Q., Minh, P. N., Dötsch, A., Hildebrand, F., Panmanee, W., Elfarash,
A., et al. (2012). Global regulation of gene expression by OxyR in an
important human opportunistic pathogen. Nucleic Acids Res. 40, 4320–4333.
doi: 10.1093/nar/gks017
Xiao, R., and Kisaalita, W. S. (1997). Iron acquisition from transferrin and
lactoferrin by Pseudomonas aeruginosa pyoverdin. Microbiology 143(Pt 7),
2509–2515. doi: 10.1099/00221287-143-7-2509
Yang, L., Nilsson, M., Gjermansen, M., Givskov, M., and Tolker-Nielsen, T.
(2009). Pyoverdine and PQS mediated subpopulation interactions involved in
Pseudomonas aeruginosa biofilm formation. Mol. Microbiol. 74, 1380–1392.
doi: 10.1111/j.1365-2958.2009.06934.x
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Kang and Kirienko. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 15 September 2017 | Volume 8 | Article 1707
